Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: The Generation R Study

Human Reproduction

Volumn 27, Issue 4, 2012, Pages 1191-1201

  Snijder, Claudia A ^a   Kortenkamp, Andreas ^b   Steegers, Eric A P ^a   Jaddoe, Vincent W V ^a   Hofman, Albert ^a   Hass, Ulla ^c   Burdorf, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

analgesics; cryptorchidism; hypospadia; paracetamol; pregnancy

Indexed keywords

ANALGESIC AGENT; PARACETAMOL;

ADULT; ARTICLE; CRYPTORCHISM; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HYPOSPADIAS; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PROGENY; QUESTIONNAIRE;

EID: 84858424415     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der474     Document Type: Article

References (34)

1. Anderson BJ. Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth 2008;18:915-921.
2. Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006;79:9-19.
3. Berkowitz GS, Lapinski RH. Risk factors for cryptorchidism: a nested case-control study. Paediatr Perinat Epidemiol 1996;10:39-51.
4. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004;363:1264-1269.
5. Chacko JK, Barthold JS. Genetic and environmental contributors to cryptorchidism. Pediatr Endocrinol Rev 2009;6:476-480.
6. De Muinck Keizer-Schrama SM. Consensus on management of the undescended testis. Ned Tijdschr Geneeskd 1987;131:1817-1821.
7. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 2010;686:349-364.
8. Foresta C, Zuccarello D, Garolla A, Ferlin A. Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev 2008;29:560-580.
9. Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl 2006; 29:140-147.
10. Gravel A, Vijayan MM. Salicylate disrupts interrenal steroidogenesis and brain glucocorticoid receptor expression in rainbow trout. Toxicol Sci 2006;93:41-49.
11. Greenland S, Finkle WD. A critical look at methods for handling missing factors in epidemiologic regression analyses. Am J Epidemiol 1995;142: 1255-1264.
12. Greenland S, Mickey RM. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;130:1066.
13. Gupta C, Bentlejewski CA. Role of prostaglandins in the testosteronedependent wolffian duct differentiation of the fetal mouse. Biol Reprod 1992;47:1151-1160.
14. Gupta C, Goldman AS. The arachidonic acid cascade is involved in the masculinizing action of testosterone on embryonic external genitalia in mice. Proc Natl Acad Sci USA 1986;83:4346-4349.
15. Hutson JM, Hasthorpe S, Heyns CF. Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 1997; 18:259-280.
16. Jaddoe VW, van Duijn CM, van der Heijden AJ, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Uitterlinden AG, Verhulst FC, Hofman A. The Generation R Study: design and cohort update 2010. Eur J Epidemiol 2010;25:823-841.
17. Jensen MS, Rebordosa C, Thulstrup AM, Toft G, Sorensen HT, Bonde JP, Henriksen TB, Olsen J. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 2010;21:779-785.
18. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT. Valproic acid monotherapy in pregnancy and major congenital malformations.N Engl J Med 2010;362:2185-2193.
19. Kalfa N, Philibert P, Sultan C. Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? Int J Androl 2009;32:187-197.
20. Kristensen DM, Hass U, Lesne L, Lottrup G, Jacobsen PR, Desdoits-Lethimonier C, Boberg J, Petersen JH, Toppari J, Jensen TK et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2010;26:235-244.
21. Kristensen DM, Skalkam ML, Audouze K, Lesne L, Desdoits-Lethimonier C, Frederiksen H, Brunak S, Skakkebaek NE, Jegou B, Hansen JB et al. Many putative endocrine disruptors inhibit prostaglandin synthesis. Environ Health Perspect 2011;119:534-541.
22. Last JM. A Dictionary of Epidemiology, 4th edn. Oxford, UK: Oxford University Press, 2001.
23. Main KM, Skakkebaek NE, Toppari J. Cryptorchidism as part of the testicular dysgenesis syndrome: the environmental connection. Endocr Dev 2009;14:167-173.
24. Palmer JR, Herbst AL, Noller KL, Boggs DA, Troisi R, Titus-Ernstoff L, Hatch EE, Wise LA, Strohsnitter WC, Hoover RN. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health 2009;8:37.
25. Palmlund I, Apfel R, Buitendijk S, Cabau A, Forsberg JG. Effects of diethylstilbestrol (DES) medication during pregnancy: report from a symposium at the 10th international congress of ISPOG. J Psychosom Obstet Gynecol 1993;14:71-89.
26. Pierik FH, Burdorf A, Nijman JM, de Muinck Keizer-Schrama SM, Juttmann RE, Weber RF. A high hypospadias rate in The Netherlands. Hum Reprod 2002;17:1112-1115.
27. Pierik FH, Burdorf A, Deddens JA, Juttman RE, Weber RF. Maternal and paternal risk factors for cryptorchidism and hypospadia: a case-control study in newborn boys. Environ Health Perspect 2004; 112:1570-1576.
28. Pierik FH, Burdorf A, de Muinck Keizer-Schrama SM, Wolffenbuttel KP, Nijman JM, Juttmann RE, Weber RF. The cryptorchidism prevalence among infants in the general population of Rotterdam, the Netherlands. Int J Androl 2005;28:248-252.
29. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972-978.
30. Statistics Netherlands. More use of health care facilities over the past 30 years. The Hague: Statistics Netherlands, 2011. Available at: http://www.cbs.nl/en-GB/menu/themas/gezondheid-welzijn/publicaties/artikelen/ archief/2011/2011-3301-wm.htm (November 2011, date last accessed).
31. Toppari J. Environmental endocrine disrupters. Sex Dev 2008;2: 260-267.
32. Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res 2010;88:910-919.
33. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, Sharpe RM. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008;118:1479-1490.
34. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005;193:771-777.